AURA vs SGMT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AURA · Aura Biosciences$6.56 ▲ 3.47%
SGMT · Sagimet Biosciences$9.85 ▲ 8.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AURA +18.8%
- SGMT +18.2%
Head to head
| Metric | AURA | SGMT |
|---|---|---|
| Price | $6.56 | $9.85 |
| Change today | ▲ 3.47% | ▲ 8.00% |
| Market cap | $680.30M | $698.45M |
| Return, 3 months | -14.8% | +2.9% |
| Return, year to date | +20.4% | +66.4% |
| Return, 1 year | +22.6% | +31.0% |
| P/E (TTM) | – | – |
| P/B | 2.2 | 2.7 |
| P/E percentile vs own 5y | 76th | 11th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | -68.9% | -34.3% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | -53.5% | -24.4% |
| Analyst target vs. price | +212.5% | +188.9% |
| Analyst buy share | 100% | 92% |
| RSI (14) | 54 | 52 |
| 30-day volatility | 45.5% | 85.9% |
| Max drawdown, 1 year | -32.6% | -48.4% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SGMT is the largest of the group by market value.
- SGMT has returned the most over the past year.
- AURA has been the calmest stock over the last 30 days.